TITLE

Use of histological and genetic markers in optimizing therapy for patients with non-small-cell lung cancer

AUTHOR(S)
Adams, Val R.; Sheth, Sheetal
PUB. DATE
January 2010
SOURCE
American Journal of Health-System Pharmacy;1/1/2010, Vol. 67 Issue 1, pS1
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article discusses the use of histological and genetic markers in the therapy optimization of non-small-cell lung cancer (NSCLC) patients in the U.S. Study demonstrates that the response to therapy among these patients may differ for patients with adenocarcinoma versus squamous cell carcinoma. It points out that advances in tumor biology led to the integration of biological agents in various regimens.
ACCESSION #
47427233

 

Related Articles

  • Different Biomarkers in Non-Small Cell Lung Cancer in Blood Vessel Invasion. Zhang, Chunyu; Liu, Ying; Guo, Shengnan; Zhang, Jie // Cell Biochemistry & Biophysics;Nov2014, Vol. 70 Issue 2, p777 

    In clinical settings, lung cancer is divided into small cell lung cancer and non-small cell lung cancer, and chemotherapy is depended on the difference. Using the same chemotherapy treatment, different effects and prognosis can be seen among squamous-cell carcinoma and adenocarcinoma. These...

  • Use of histological and genetic markers in optimizing therapy for patients with non-small-cell lung cancer. Adams, Val R.; Harvey, R. Donald // American Journal of Health-System Pharmacy;1/1/2010, Vol. 67 Issue 1, pS3 

    Purpose. To describe how molecular and genetic markers influence the response to therapy in patients with advanced nonsmall- cell lung cancer (NSCLC). Summary. Cisplatin resistance has been associated with high rates of expression of endonucleases, a family of DNA repair proteins that includes...

  • Use of histological and genetic markers in optimizing therapy for patients with non-small-cell lung cancer.  // American Journal of Health-System Pharmacy;1/1/2010, Vol. 67 Issue 1, pS15 

    A quiz concerning the use of histological and genetic markers in the therapy optimization of non-small-cell lung cancer patients.

  • Minimally Invasive Esophagectomy in a Previously Pneumonectomized Patient. Petri, Roberto; Brizzolari, Marco; Sorrentino, Mario; Bassi, Flavio; Muzzi, Rodolfo; Zuccolo, Marco // Journal of Laparoendoscopic & Advanced Surgical Techniques;Sep2012, Vol. 22 Issue 7, p695 

    Introduction: Surgical resection represents the only therapeutic action having a radical intent for the treatment of resectable esophageal neoplasms. Minimally invasive esophagectomy for esophageal cancer is being more and more frequently performed. Few cases of esophagectomy after pneumonectomy...

  • Therapeutic decisionmaking in the molecular era. Blais, Normand // Oncology Exchange;Feb2014, Vol. 13 Issue 1, p16 

    Current treatment based algorithms for NSCLC are often derived from studies that were conducted prior to the extensive wealth of knowledge that was gained by subtyping lung cancer into distinct molecular entities. New studies are now helping to refine strategies for second-line approaches in...

  • Scientific and technical education. Balzer, Harley D. // Bulletin of the Atomic Scientists;Aug/Sep1982, Vol. 38 Issue 7, p24 

    The article focuses on the significant progress that has been made in the Soviet Union's educational system. The non-classical secondary school was considered the orphan of pre-Revolutionary Russian education. Pre-Revolutionary education ministers aimed to give higher education for children from...

  • O3–086PHASE II STUDY OF TAILORED DOSE S-1 PLUS CARBOPLATIN FOLLOWED BY S-1 FOR ADVANCED SQUAMOUS CELL LUNG CANCER. Yuh, N.; Komuta, K.; Yokoi, T.; Yamamoto, S.; Minami, S.; Shiroyama, T.; Hirashima, T.; Namba, Y.; Kijima, T.; Tachibana, I. // Annals of Oncology;Nov2013 Supplement 9, Vol. 24, pix62 

    No abstract available.

  • Nanodiamond internalization in cells and the cell uptake mechanism. Perevedentseva, E.; Hong, S.-F.; Huang, K.-J.; Chiang, I.-T.; Lee, C.-Y.; Tseng, Y.-T.; Cheng, C.-L. // Journal of Nanoparticle Research;Aug2013, Vol. 15 Issue 8, p1 

    Cell type-dependent penetration of nanodiamond in living cells is one of the important factors for using nanodiamond as cellular markers/labels, for drug delivery as well as for other biomedical applications. In this work, internalization of 100 nm nanodiamonds by A549 lung human adenocarcinoma...

  • Identification of Biomarker and Co-Regulatory Motifs in Lung Adenocarcinoma Based on Differential Interactions. Zhao, Ning; Liu, Yongjing; Chang, Zhiqiang; Li, Kening; Zhang, Rui; Zhou, Yuanshuai; Qiu, Fujun; Han, Xiaole; Xu, Yan // PLoS ONE;9/24/2015, Vol. 10 Issue 9, p1 

    Changes in intermolecular interactions (differential interactions) may influence the progression of cancer. Specific genes and their regulatory networks may be more closely associated with cancer when taking their transcriptional and post-transcriptional levels and dynamic and static...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics